Share Sarcoma Sisters
Share to email
Share to Facebook
Share to X
SARC (Sarcoma Alliance for Research through Collaboration) is a non-profit organization dedicated to the development and support of research for the prevention, treatment, and cure of sarcomas – a cancer of the bone and connective tissue of the body.
Dr. Kopp and Dr. Allen-Rhoades join Dr. Scott Okuno, SARCs Chief Medical Officer, for a conversation about the history of the Sarcoma Sisters and how they are hoping to help patients and loved ones navigate their sarcoma diagnosis through their podcast.
Dr. George is a medical oncologist and Associate Professor at Harvard Medical School. She is the Clinical Director at the Center for Sarcoma and Bone Oncology at Dana-Farber Cancer Institute with over 20 years experience of treating patients throughout the world with sarcoma. She is actively involved in the clinical research and works to develop new clinical trials focusing on therapy for metastatic soft tissue sarcoma.
In this episode we discuss:
music: Rosepigg
photo: nine koepfer
Kate also works at Fred Hutchinson Research Center in Seattle, WA as the nutrition advisor and editor for the Cook for Your Life website providing science-based guidelines, recipes, and tips to those who have been touched by cancer.
The Fred Hutch Cook For Your Life website is such an amazing resource that everyone needs to check out no matter where you are in your cancer journey!
We learn from Kate what led her into nutrition and oncology.
In this episode we touch on a many nutritional oncology topics:Fred Hutch Cook For Your Life
Photo credit: Anna Pelzer
Music: RosePigg
Dr. Dan Steventon is a Doctor of Physical Therapy and practices at The Sanford Children’s Castle of Care Hospital in Sioux Falls, South Dakota. He specializes in pediatric cancer physical therapy. However, outside of the amazing care he gives his patients, he has a robust social media educational platform and is known as PT Dan The Kids Cancer PT!
We encourage you to check him out on twitter
And his You Tube Channel including his special series on rotationplasty for Sarcoma Awareness Month!
We discuss:
Music: Rosepigg
Photo: Raspopva Marina
Dr. R. Lor Randall is an Orthopedic Oncologic surgeon who is a world renowned expert in sarcoma orthopedic surgery. He is the David Linn Endowed Chair for Orthopaedic Surgery; Chair, Department of Orthopaedic Surgery and Professor, Department of Orthopaedic Surgery at the University of California, Davis in Sacramento.
Dr. Randall’s clinical practice and research focus on musculoskeletal surgical oncology and on building-leading edge trans-disciplinary teams to combat rare cancers of connective tissue in children and adults.
In this episode we discuss:
As promised in the interview:
Dr. Janeway is a pediatric oncologist and senior physician at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. She is the Director of Clinical Genomics at Dana-Farber Cancer Institute and her research is focused on genomics, precision oncology and bone sarcomas. She leads clinical trials in osteosarcoma and Ewing sarcoma both as an independent investigator and as the Chair of the Children’s Oncology Group (COG) Bone Tumor Committee.
In this episode we discuss:
music Rosepigg
photo Eric Prouzet
Dr. Aaron Weiss is a board certified pediatric hematologist/oncologist practicing in Maine. He is an associate professor and the Division Director of Pediatric Hematology-Oncology at Tufts University School of Medicine and he holds the Sam L Cohen Medical Director Endowed Chair at Maine Children’s Cancer Program. As part of Children's Oncology Group he is the Vice-Chair of the Soft Tissue Sarcoma Committee, and the Associate Vice-Chair of the Clinical Trials, AYA Oncology Discipline Committee. He is an expert in Desmoid tumors and he is the chair of the Desmoid Tumor Research Foundation Medical Advisory Board.
In this episode we discuss:
- What led Dr. Weiss into his expertise of soft tissue sarcomas and specifically Desmoid tumors
- Is a Desmoid tumor and cancer and why does the cancer classification matter?
- Where do Desmoid tumors occur and the profound affect on quality of life for patients
- Should the clinical trial endpoints for Desmoid tumors change?
- All areas of Desmoid tumor treatment including: - Localized treatment such as high intensity ultrasound - Systemic treatment from chemotherapy to targeted therapies - The importance of active surveillance as a treatment option - Why some treatments have fallen out of favor and what is on the horizon
music: Rospigg
photo: Felix-Mittermeier
Dr. Allen-Rhoades and Dr. Kopp discuss the results of the recently published Ewing Sarcoma clinical trial - Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group Report.
We mention in the episode that the full article is accessible, however, it is only if you purchase individually - bummer. However, the link Is here for the article abstract and if you would like to purchase.
We discuss the clinical trial in detail including background on previous trials, methods, results and how these results affect current and future treatment of patients with Ewing sarcoma. Thank you for listening and please let us know your thoughts!
Dr. Ishwaria Subbiah is a palliative care physician and medical oncologist in the Division of Cancer Medicine at MD Anderson Cancer Center in Houston, TX. She is uniquely qualified for this role, having completed training at MD Anderson, not only in medical oncology but also in Phase 1 drug development and Palliative Medicine. With all this training she sees patients in the palliative care clinic and also conducts clinical research that focuses on symptom management and patient centered supportive care that is driven by patient-reported outcomes (PROs) with an emphasis on older adult participation on clinical trials. She also works on developing palliative care initiatives and PROs on the national and international level.
You can find Dr. Subbiah on social media including twitter where she is very active. In this episode we discuss defining palliative care what interested Dr. Subbiah in palliative care the difference between palliative care and hospice care benefits of palliative care why palliative care is critical to cancer care breadth of palliative care team caregiver experience the future of palliative careImage credit National Cancer Institute
Music Rospigg
Dr. Wilky is the Director of Sarcoma Medical Oncology at the University of Colorado. She cares for patients over the age of 18 with every type of sarcoma and is an expert not only in traditional chemotherapy treatments for sarcomas, but also at using modern technology such as gene sequencing and molecular profiling to identify out-of-the-box treatments particularly in targeted therapy. Dr. Wilky is also a translational researcher who conducts and designs clinical trials for sarcoma patients, with a focus on early immunotherapy protocols. Her laboratory studies the interaction between sarcomas and the immune system. Additionally, Dr. Wilky leads the investigator-initiated clinical trials committee at the University of Colorado Cancer Center, helping other researchers bring laboratory science discoveries into human clinical trials
You can get so much great information about sarcoma and treatments by following Dr. Wilky on social media on Twitter or on her blog
In this episode we discuss:
music: Rospigg
photo credit: volodymyr-hrysh
The podcast currently has 21 episodes available.